"Designation really helps drive pps last couple of days. Really favorable towards FDA approval. Heard through the grapevine that CLDX CDX011 in breast cancer is also candidate for Breakthrough Therapy designation. Looks like FDA is focusing on cancer drugs at this point."
poster is evidns_based
OT - I owned PCYC from the 4's to the 6's. Today it's trading at new highs of 80+. I see similar things in CLDX's future